U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill_老虎社区_美港股上老虎

U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill

Bloomberg2021-11-04

Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective. The U.K.’s Medicines and Healthcare ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

b1uesky
·2021-11-06
Great
回复
3
举报
收起
- 滚股怪:
  Ye
  2021-11-06
  回复
  举报
koolgal
·2021-11-05
Great news for Merck with the UK drug regulator's approval. It is only a matter of time before the Merck Covid Pill gain wide approval around the world! Go Merck! 🚀🚀🚀🌙🌙🌙
回复
22
举报
收起
- koolgal:
  To the moon 🚀🚀🚀🌙🌙🌙
  2021-11-06
  回复
  举报
- koolgal:
  Thanks
  2021-11-06
  回复
  举报
- koolgal:
  Thanks
  2021-11-06
  回复
  举报
查看更多 2 条评论
FannyNg
·2021-11-05
This oral drug would be game changer to help speed up the economic recovery if proven successful.
回复
1
举报
AetherC
·2021-11-05
Its about time to have an oral drug
回复
1
举报
littlekitten
·2021-11-05
Cool
回复
4
举报
Rapdog
·2021-11-04
Great [得意]
回复
3
举报
jayfalcon
·2021-11-04
Great 👍
回复
3
举报
TKangWM
·2021-11-04
👍
回复
3
举报
收起
- EmChung:
  👍🏼
  2021-11-04
  回复
  举报
Eaglewings
·2021-11-04
Great to have a treatment to control the spread
回复
2
举报
CT131605
·2021-11-04
Interesting
回复
3
举报
AngieAbcde
·2021-11-04
Too late to buy?
回复
5
举报
收起
- JeremyKok:
  buy during the dip and hold for the long term. but do your own due diligence before you invest.
  2021-11-05
  回复
  举报
Ionics
·2021-11-04
Lnc pls ty
回复
2
举报
收起
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-11-05
  回复
  举报
BoonHuat
·2021-11-04
Good news.
回复
2
举报
收起
- Ionics:
  C bk pls ty
  2021-11-04
  回复
  举报
Kel9670ong
·2021-11-04
Not bad. Another oral vaccine
回复
5
举报
LimHianYew
·2021-11-04
Good news
回复
8
举报
收起
- NEWBIE:
  yes good news
  2021-11-04
  回复
  举报
- SALLY123:
  Ok
  2021-11-04
  回复
  举报
- CasperLai:
  Leave 1 comment
  2021-11-04
  回复
  举报
SkyLim
·2021-11-04
Ok
回复
8
举报
收起
- SkyLim:
  ok
  2021-11-04
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1167697278?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-04 19:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167697278","market":"us","top_or_hot":-1,"title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","media":"Bloomberg","content":"<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRK","symbol_name":"默沙东","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","article_id":"1167697278","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","pubTimestamp":1636025569,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRK":"默沙东"},"translate_title":"英国药品监管机构首次批准默克公司的新冠肺炎药丸","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9},"content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":842145676,"gmtCreate":1636158524703,"gmtModify":1636158524885,"author":{"id":"4096368443831390","authorId":"4096368443831390","name":"b1uesky","avatar":"https://static.tigerbbs.com/87ef9b02e19a8acfaa7ae5b147b70882","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842145676","repostId":1167697278,"repostType":2,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6474423,"gmtCreate":1636168978065,"gmtModify":1636168978095,"authorId":4091089381144950,"author":{"id":4091089381144950,"authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":842145676,"type":1,"supId":0,"prevId":0,"content":"Ye","text":"Ye","html":"Ye"}],"langContent":"CN"},{"id":846430841,"gmtCreate":1636102930951,"gmtModify":1636155904033,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Great news for Merck with the UK drug regulator's approval.&nbsp; It is only a matter of time before the Merck Covid Pill gain wide approval around the world! Go Merck! 🚀🚀🚀🌙🌙🌙","listText":"Great news for Merck with the UK drug regulator's approval.&nbsp; It is only a matter of time before the Merck Covid Pill gain wide approval around the world! Go Merck! 🚀🚀🚀🌙🌙🌙","text":"Great news for Merck with the UK drug regulator's approval. It is only a matter of time before the Merck Covid Pill gain wide approval around the world! Go Merck! 🚀🚀🚀🌙🌙🌙","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":22,"commentSize":10,"repostSize":1,"link":"https://laohu8.com/post/846430841","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6471160,"gmtCreate":1636155904008,"gmtModify":1636155904008,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846430841,"type":1,"supId":6466355,"prevId":0,"content":"To the moon 🚀🚀🚀🌙🌙🌙","text":"To the moon 🚀🚀🚀🌙🌙🌙","html":"To the moon 🚀🚀🚀🌙🌙🌙"},{"id":6471156,"gmtCreate":1636155890348,"gmtModify":1636155890348,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846430841,"type":1,"supId":6470234,"prevId":0,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":6471154,"gmtCreate":1636155885052,"gmtModify":1636155885052,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846430841,"type":1,"supId":6471143,"prevId":0,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":6471153,"gmtCreate":1636155876776,"gmtModify":1636155876776,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846430841,"type":1,"supId":6471145,"prevId":0,"content":"Yes! 🚀🚀🚀🌙🌙🌙","text":"Yes! 🚀🚀🚀🌙🌙🌙","html":"Yes! 🚀🚀🚀🌙🌙🌙"},{"id":6471145,"gmtCreate":1636155829851,"gmtModify":1636155829893,"authorId":4091242831202010,"author":{"id":4091242831202010,"authorId":4091242831202010,"name":"tklew","avatar":"https://static.tigerbbs.com/b99cfe4b0a492018c40761a39a193aa8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846430841,"type":1,"supId":0,"prevId":0,"content":"上火箭咯 [财迷] [财迷]","text":"上火箭咯 [财迷] [财迷]","html":"上火箭咯 [财迷] [财迷]"}],"langContent":"CN"},{"id":846289203,"gmtCreate":1636086010235,"gmtModify":1636086448681,"author":{"id":"3570078045081862","authorId":"3570078045081862","name":"FannyNg","avatar":"https://static.tigerbbs.com/26a7e220cf6527fe231925dee915cd17","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"This oral&nbsp;drug would be game changer to help speed up the economic recovery if proven successful.&nbsp;","listText":"This oral&nbsp;drug would be game changer to help speed up the economic recovery if proven successful.&nbsp;","text":"This oral drug would be game changer to help speed up the economic recovery if proven successful.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846289203","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846697358,"gmtCreate":1636076487332,"gmtModify":1636076487997,"author":{"id":"3582258408396089","authorId":"3582258408396089","name":"AetherC","avatar":"https://static.tigerbbs.com/0e9d2b2288d3ec3cb10339c5902876c8","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Its about time to have an oral drug","listText":"Its about time to have an oral drug","text":"Its about time to have an oral drug","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846697358","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846102761,"gmtCreate":1636065730030,"gmtModify":1636065730483,"author":{"id":"3584860762907200","authorId":"3584860762907200","name":"littlekitten","avatar":"https://static.tigerbbs.com/ccd59ff6c96999c839e3b5709cfb00ef","vip":1,"crmLevel":7,"crmLevelSwitch":0},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846102761","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846928749,"gmtCreate":1636040839449,"gmtModify":1636040839563,"author":{"id":"3570877693225065","authorId":"3570877693225065","name":"Rapdog","avatar":"https://static.tigerbbs.com/539ed1f3dfd2b609e8dafdf2714b309c","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Great&nbsp;[得意]&nbsp;","listText":"Great&nbsp;[得意]&nbsp;","text":"Great [得意]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846928749","repostId":1167697278,"repostType":2,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846968667,"gmtCreate":1636040138260,"gmtModify":1636040138746,"author":{"id":"4090418835913750","authorId":"4090418835913750","name":"jayfalcon","avatar":"https://static.tigerbbs.com/505029b8d840d52745c57c2cbf910d5c","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Great 👍","listText":"Great 👍","text":"Great 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846968667","repostId":1167697278,"repostType":2,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846032515,"gmtCreate":1636034485136,"gmtModify":1636034587425,"author":{"id":"3582197285087556","authorId":"3582197285087556","name":"TKangWM","avatar":"https://static.tigerbbs.com/e6d5c7cfa41fb45c160ed7c4af893e54","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846032515","repostId":1167697278,"repostType":2,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6454415,"gmtCreate":1636036758817,"gmtModify":1636036758925,"authorId":3566723689439669,"author":{"id":3566723689439669,"authorId":3566723689439669,"name":"EmChung","avatar":"https://static.tigerbbs.com/99db9b9b2d5d303db43970c31a6ba528","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846032515,"type":1,"supId":0,"prevId":0,"content":"👍🏼","text":"👍🏼","html":"👍🏼"}],"langContent":"CN"},{"id":848728308,"gmtCreate":1636031488240,"gmtModify":1636031527518,"author":{"id":"3574484198588936","authorId":"3574484198588936","name":"Eaglewings","avatar":"https://static.tigerbbs.com/532f4e45cb093f21d9a38905184a4bb9","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Great to have a treatment to control the spread&nbsp;","listText":"Great to have a treatment to control the spread&nbsp;","text":"Great to have a treatment to control the spread","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848728308","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":848768574,"gmtCreate":1636030701893,"gmtModify":1636030702008,"author":{"id":"3575511822003150","authorId":"3575511822003150","name":"CT131605","avatar":"https://static.tigerbbs.com/e7dc91053dde2a04c818db545bbb9ae7","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848768574","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":848799548,"gmtCreate":1636026510258,"gmtModify":1636026778071,"author":{"id":"3582760464345135","authorId":"3582760464345135","name":"AngieAbcde","avatar":"https://static.tigerbbs.com/afd4bd4f4d998862f09bdc2916fcc2ab","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Too late to buy?","listText":"Too late to buy?","text":"Too late to buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848799548","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6457648,"gmtCreate":1636067805169,"gmtModify":1636067805203,"authorId":3567307840510045,"author":{"id":3567307840510045,"authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848799548,"type":1,"supId":0,"prevId":0,"content":"buy during the dip and hold for the long term. but do your own due diligence before you invest.","text":"buy during the dip and hold for the long term. but do your own due diligence before you invest.","html":"buy during the dip and hold for the long term. but do your own due diligence before you invest."}],"langContent":"CN"},{"id":848799122,"gmtCreate":1636026467371,"gmtModify":1636026756906,"author":{"id":"3577074370445232","authorId":"3577074370445232","name":"Ionics","avatar":"https://static.tigerbbs.com/fe0ce605bd3d4fc95288fb66b3064296","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Lnc pls ty","listText":"Lnc pls ty","text":"Lnc pls ty","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848799122","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6457629,"gmtCreate":1636067758650,"gmtModify":1636067758684,"authorId":3567307840510045,"author":{"id":3567307840510045,"authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848799122,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."}],"langContent":"CN"},{"id":848790886,"gmtCreate":1636026362665,"gmtModify":1636026754809,"author":{"id":"3574549633778650","authorId":"3574549633778650","name":"BoonHuat","avatar":"https://static.tigerbbs.com/f64154b666040668c472fc3731becde7","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Good news.","listText":"Good news.","text":"Good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848790886","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6452372,"gmtCreate":1636026484553,"gmtModify":1636026484646,"authorId":3577074370445232,"author":{"id":3577074370445232,"authorId":3577074370445232,"name":"Ionics","avatar":"https://static.tigerbbs.com/fe0ce605bd3d4fc95288fb66b3064296","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848790886,"type":1,"supId":0,"prevId":0,"content":"C bk pls ty ","text":"C bk pls ty ","html":"C bk pls ty "}],"langContent":"CN"},{"id":848704659,"gmtCreate":1636026129907,"gmtModify":1636026131035,"author":{"id":"3578468158955348","authorId":"3578468158955348","name":"Kel9670ong","avatar":"https://static.tigerbbs.com/bd86c42e207fbd94e7f8877a29457d71","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Not bad. Another oral vaccine","listText":"Not bad. Another oral vaccine","text":"Not bad. Another oral vaccine","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848704659","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":848702288,"gmtCreate":1636025996636,"gmtModify":1636025997406,"author":{"id":"3576363559636103","authorId":"3576363559636103","name":"LimHianYew","avatar":"https://static.tigerbbs.com/6d37a520eb4e35950b060938ddb5e317","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/848702288","repostId":1167697278,"repostType":2,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6452326,"gmtCreate":1636026276527,"gmtModify":1636026276637,"authorId":3573124416025977,"author":{"id":3573124416025977,"authorId":3573124416025977,"name":"NEWBIE","avatar":"https://static.tigerbbs.com/3efe20248e6d34805e6c7befc3ae66a0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848702288,"type":1,"supId":6452273,"prevId":0,"content":"yes good news","text":"yes good news","html":"yes good news"},{"id":6452288,"gmtCreate":1636026088657,"gmtModify":1636026088765,"authorId":3586512925725941,"author":{"id":3586512925725941,"authorId":3586512925725941,"name":"SALLY123","avatar":"https://static.tigerbbs.com/3645082e74bb8034e0163391e44f18e8","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848702288,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6452273,"gmtCreate":1636026040676,"gmtModify":1636026040713,"authorId":3568766180831566,"author":{"id":3568766180831566,"authorId":3568766180831566,"name":"CasperLai","avatar":"https://static.tigerbbs.com/c5e9fab991a16c3f76bc62ae577aab33","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848702288,"type":1,"supId":0,"prevId":0,"content":"Leave 1 comment","text":"Leave 1 comment","html":"Leave 1 comment"}],"langContent":"CN"},{"id":848706273,"gmtCreate":1636025889847,"gmtModify":1636025944052,"author":{"id":"3581901940644351","authorId":"3581901940644351","name":"SkyLim","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848706273","repostId":1167697278,"repostType":4,"repost":{"id":"1167697278","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck &amp; Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6452250,"gmtCreate":1636025942186,"gmtModify":1636025942214,"authorId":3581901940644351,"author":{"id":3581901940644351,"authorId":3581901940644351,"name":"SkyLim","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848706273,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":95,"commentSize":16,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}